Benitec Biopharma Inc.
BNTCNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $393.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $8.25$16.76
- Volume (live)
- -
- Avg. volume (3M)
- 175.30K
Benitec Biopharma (BNTC) Stock Price & Financial Analysis
Benitec Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.34 - $8.76 |
|---|---|
| 52-Week High | $16.76 |
| 52-Week Low | $8.25 |
| Open | $8.37 |
| Volume (last close) | 153.73K |
| Average Volume (3M) | 175.30K |
| 50-Day MA | $11.45 |
|---|---|
| 200-Day MA | $11.77 |
| 1-Year Change | −46.11% |
| Market Cap | 393.88M |
|---|---|
| Shares Outstanding | 46.56M |
| Price to Book (P/B) | 2.23 |
| EV/EBITDA | -4.22 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jun 1, 2018 |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Benitec Biopharma at a Glance
As of the Oct 15, 2026 close, Benitec Biopharma (BNTC) has a market capitalization of $393.88M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $179.97M in cash and securities against $762.00K of debt, a net cash position of $179.21M.
Benitec Biopharma does not currently pay a dividend.
The share price is down 46.1% over the past year. At $8.46 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $8.25 to $16.76, below its 200-day moving average of $11.77.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $24.67, 191.6% above the Oct 15, 2026 close.
Frequently Asked Questions About Benitec Biopharma
What is the current stock price for BNTC?
As of the Oct 15, 2026 close, BNTC stock trades at $8.46. The 52-week range is $8.25–$16.76, with a day range of $8.34–$8.76.
What is the P/E ratio for BNTC?
The P/E ratio (Price-to-Earnings) for BNTC is shown in the Key Statistics section. This valuation metric helps compare Benitec Biopharma Inc. to industry peers.
Does BNTC pay dividends?
Benitec Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BNTC?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for BNTC is Buy. The average 12-month price target is $24.67, a 191.6% upside from the Oct 15, 2026 close of $8.46.
What is the market cap of BNTC?
As of the Oct 15, 2026 close, Benitec Biopharma's market capitalization is $393.9M, classifying it as a small-cap company. Benitec Biopharma operates in the Healthcare sector within the Biotechnology industry.